Join to view full profile
199 Reedsdale RdMilton, MA 02186
Phone+1 781-474-3255
Dr. Popkin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Popkin was an oncologist based in Norwood, MA. He now sees patients with the Beth Israel Extended Care Community Program and as a floating provider for their primary care offices. He graduated from Boston University School of Medicine in 1977 and completed his residency in Internal Medicine at the Boston VA Healthcare System. His published research includes a study on the estrogen receptor's nuclear binding as a hormone response predictor in metastatic breast cancer and a trial on treatments for advanced non-small cell lung cancer, both of which have been cited six times. He has also received CMS Meaningful Use Stage 1 Certification from eClinicalWorks EHR in 2012-2013.
Education & Training
Boston VA Healthcare System (Brockton-West Roxbury)Residency, Internal Medicine, 1977 - 1982
Boston University School of MedicineClass of 1977
Certifications & Licensure
MA State Medical License 1978 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- 6 citationsNuclear binding of the estrogen receptor: a potential predictor for hormone response in metastatic breast cancer.Nicholas J. Robert, Leslie A. Martin, C. Douglas Taylor, James Popkin, David R. Parkinson
Breast Cancer Research and Treatment. 1990-10-01 - 6 citationsA Prospective Randomized Trial of Combination Vindesine and Cisplatin Versus Single‐agent Vindesine in Advanced Non‐small Cell Lung CancerJames D. Popkin, Waun Ki Hong, Robert J. Cersosimo, L. Jack Faling, Marylou N. Snow
Pharmacotherapy. 1985-01-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
